Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous Carcinoma

被引:32
|
作者
Bassiouny, Dina [1 ,2 ,3 ]
Ismiil, Nadia [1 ,2 ]
Dube, Valerie [1 ,2 ]
Han, Guangming [1 ,2 ]
Cesari, Matthew [1 ,2 ]
Lu, Fang-I [1 ,2 ]
Slodkowska, Elzbieta [1 ,2 ]
Parra-Herran, Carlos [1 ,2 ]
Chiu, Hak Fai [1 ]
Naeim, Magda [1 ]
Li, Nim [1 ]
Khalifa, Mahmoud [1 ,2 ]
Nofech-Mozes, Sharon [1 ,2 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Mansoura Univ, Mansoura, Egypt
关键词
ovarian cancer; mucinous; immunohistochemistry; SATB2; HER2; PAX8; napsin A; HNFlb; LYMPH-NODE METASTASIS; CLEAR-CELL CARCINOMA; DIFFERENTIAL-DIAGNOSIS; ENDOMETRIOID CARCINOMA; TUMOR-SUPPRESSOR; SATB2; EXPRESSION; LYNCH SYNDROME; BREAST-CANCER; ARID1A; ADENOCARCINOMA;
D O I
10.1177/1066896917752861
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The distinction of primary mucinous ovarian carcinoma (PMOC) from other primaries or secondaries is essential for selecting therapeutic options and prognostication. We aimed to characterize the immunohistochemical profile of 36 PMOCs using an extended immunohistochemical panel, with clinicopathologic features and outcome. PAX8 was negative in 30 (83.3%), and SATB2 was negative in 32/35. HNF1B, AMACR, and napsin-A were detected in 33 (91.7%), 35 (97.2%), and 0 (0%), respectively. MMR proteins and ARID1A were retained in 100%; PTEN was lost in 4 (11.1%). P53 was aberrant in 10 (27.8%); none overexpressed p16. HER2 was positive in 6/35 (17.1%). Most PMOCs had a favorable outcome. However, recurrence is usually fatal. The typical tumor profile was CK7+, CK20+/-, CDX2+/-, PAX8-, ER-, PgR-, and SATB2-. HER2 positivity suggests a possible target for therapy in advanced disease.
引用
收藏
页码:306 / 317
页数:12
相关论文
共 50 条
  • [31] Immunohistochemical Techniques To Differentiate Primary Versus Metastatic Mucinous Carcinoma in the Skin
    Levy, G.
    Finkelstein, A.
    McNiff, J.
    MODERN PATHOLOGY, 2009, 22 : 105A - 105A
  • [32] Immunohistochemical Techniques To Differentiate Primary Versus Metastatic Mucinous Carcinoma in the Skin
    Levy, G.
    Finkelstein, A.
    McNiff, J.
    LABORATORY INVESTIGATION, 2009, 89 : 105A - 105A
  • [33] Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases
    Tabrizi, Ali Dastranj
    Kalloger, Steve E.
    Koebel, Martin
    Cipollone, Jane
    Roskelley, Calvin D.
    Mehl, Erika
    Gilks, C. Blake
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2010, 29 (02) : 99 - 107
  • [34] Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma - A clinicopathologic and immunohistochemical study of five cases
    Young, RH
    Hart, WR
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (07) : 805 - 815
  • [35] OVARIAN HYPERTHECOSIS - AN IMMUNOHISTOCHEMICAL AND CLINICOPATHOLOGIC STUDY
    FUKUNAGA, M
    SASANO, H
    SILVERBERG, SG
    LABORATORY INVESTIGATION, 1989, 60 (01) : A31 - A31
  • [36] Ovarian nonsmall cell neuroendocrine carcinoma - A clinicopathologic and immunohistochemical study of 11 cases
    Veras, Emanuela
    Deavers, Michael T.
    Silva, Elvio G.
    Malpica, Anais
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (05) : 774 - 782
  • [37] PRIMARY-CARCINOMA OF THE SMALL-INTESTINE - A CLINICOPATHOLOGIC AND IMMUNOHISTOCHEMICAL STUDY
    LIEN, GS
    MORI, M
    ENJOJI, M
    CANCER, 1988, 61 (02) : 316 - 323
  • [38] Prognosis in primary mucinous ovarian carcinoma: focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary
    Lee, Sang Won
    Sung, Jung-A
    Jung, Minsun
    Kim, Haeryoung
    Lee, Cheol
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (02)
  • [39] Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma
    Halperin, R
    Zehavi, S
    Hadas, E
    Habler, L
    Bukovsky, I
    Schneider, D
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2001, 20 (04) : 341 - 345
  • [40] Mucinous carcinomas of the ovary: Immunohistochemistry can help distinguish primary mucinous ovarian carcinoma from metastatic mucinous carcinoma of appendiceal origin
    Hirsch, MS
    Hornick, JL
    MODERN PATHOLOGY, 2005, 18 : 185A - 186A